1.
Mol Genet Metab
; 125(3): 276-280, 2018 11.
Article
in English
| MEDLINE
| ID: mdl-30217722
ABSTRACT
Three young patients with glutaric aciduria type I (age 6-23â¯years) of different ethnic origins, treated for their metabolic disease since early childhood, presented with malignant central nervous system tumors. We recommend continuing clinical follow-up, including monitoring of neurological manifestations and neuroradiological findings, in all patients with glutaric aciduria type I beyond early childhood, especially if adherence to diet is poor or the treatment was not started neonatally.